151 related articles for article (PubMed ID: 36256902)
21. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
[TBL] [Abstract][Full Text] [Related]
22. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
[TBL] [Abstract][Full Text] [Related]
23. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular Risk Factor Disparities in Adult Survivors of Childhood Cancer Compared With the General Population.
Noyd DH; Liu Q; Yasui Y; Chow EJ; Bhatia S; Nathan PC; Landstrom AP; Tonorezos E; Casillas J; Berkman A; Ness KK; Mulrooney DA; Leisenring WM; Howell CR; Shoag J; Kirchhoff A; Howell RM; Gibson TM; Zullig LL; Armstrong GT; Oeffinger KC
JACC CardioOncol; 2023 Aug; 5(4):489-500. PubMed ID: 37614575
[TBL] [Abstract][Full Text] [Related]
25. Contribution of cardiovascular risk factors to coronary risk in patients with intermittent claudication in the PRIME Cohort Study of European men.
Tilloy E; Montaye M; Kee F; Bingham A; Arveiler D; Ruidavets JB; Evans A; Haas B; Ferrières J; Ducimetière P; Amouyel P; Dallongeville J
Atherosclerosis; 2009 Oct; 206(2):563-8. PubMed ID: 19403136
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular Disease Risk Profiles in Survivors of Adolescent and Young Adult (AYA) Cancer: The Kaiser Permanente AYA Cancer Survivors Study.
Chao C; Xu L; Bhatia S; Cooper R; Brar S; Wong FL; Armenian SH
J Clin Oncol; 2016 May; 34(14):1626-33. PubMed ID: 26951318
[TBL] [Abstract][Full Text] [Related]
27. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
[TBL] [Abstract][Full Text] [Related]
28. Late cardiotoxicity after treatment for Hodgkin lymphoma.
Aleman BM; van den Belt-Dusebout AW; De Bruin ML; van 't Veer MB; Baaijens MH; de Boer JP; Hart AA; Klokman WJ; Kuenen MA; Ouwens GM; Bartelink H; van Leeuwen FE
Blood; 2007 Mar; 109(5):1878-86. PubMed ID: 17119114
[TBL] [Abstract][Full Text] [Related]
29. Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors.
Sundbøll J; Szépligeti SK; Szentkúti P; Adelborg K; Horváth-Puhó E; Pedersen L; Henderson VW; Sørensen HT
J Am Heart Assoc; 2022 Mar; 11(5):e022768. PubMed ID: 35170978
[TBL] [Abstract][Full Text] [Related]
30. Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study.
Özcan C; Deleskog A; Schjerning Olsen AM; Nordahl Christensen H; Lock Hansen M; Hilmar Gislason G
Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):25-35. PubMed ID: 28444162
[TBL] [Abstract][Full Text] [Related]
31. Having co-morbid cardiovascular disease at time of cancer diagnosis: already one step behind when it comes to HRQoL?
Schoormans D; Husson O; Oerlemans S; Ezendam N; Mols F
Acta Oncol; 2019 Dec; 58(12):1684-1691. PubMed ID: 31389275
[No Abstract] [Full Text] [Related]
32. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
[TBL] [Abstract][Full Text] [Related]
33. Impact of cardiovascular risk factor control on long-term cardiovascular and all-cause mortality in the general population.
Bérard E; Bongard V; Dallongeville J; Arveiler D; Amouyel P; Wagner A; Cottel D; Haas B; Ruidavets JB; Ferrières J
Ann Med; 2016 Nov; 48(7):559-567. PubMed ID: 27558835
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular Family History Increases Risk for Late-Onset Adverse Cardiovascular Outcomes in Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report.
Goldberg JF; Ness KK; Chi X; Santucci AK; Plana JC; Joshi VM; Luepker RV; Durand JB; Partin RE; Howell RM; Wilson CL; Towbin JA; Jefferies JL; Srivastava DK; Hudson MM; Robison LL; Armstrong GT
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):123-132. PubMed ID: 33033146
[TBL] [Abstract][Full Text] [Related]
35. Prevalent diabetes and long-term cardiovascular outcomes in adult sepsis survivors: a population-based cohort study.
Angriman F; Lawler PR; Shah BR; Martin CM; Scales DC;
Crit Care; 2023 Jul; 27(1):302. PubMed ID: 37525272
[TBL] [Abstract][Full Text] [Related]
36. Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpura.
Brodsky MA; Sukumar S; Selvakumar S; Yanek L; Hussain S; Mazepa MA; Braunstein EM; Moliterno AR; Kickler TS; Brodsky RA; Cataland SR; Chaturvedi S
Am J Hematol; 2021 Dec; 96(12):1587-1594. PubMed ID: 34460124
[TBL] [Abstract][Full Text] [Related]
37. Late effects in survivors treated for lymphoma as adolescents and young adults: a population-based analysis.
Lo AC; Chen B; Samuel V; Savage KJ; Freeman C; Goddard K
J Cancer Surviv; 2021 Dec; 15(6):837-846. PubMed ID: 33453004
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Major Cardiovascular Events in Adult Sepsis Survivors: A Population-Based Cohort Study.
Angriman F; Rosella LC; Lawler PR; Ko DT; Martin CM; Wunsch H; Scales DC;
Crit Care Med; 2023 Apr; 51(4):471-483. PubMed ID: 36790198
[TBL] [Abstract][Full Text] [Related]
40. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
